188 related articles for article (PubMed ID: 23025519)
1. Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.
Momper JD; Zhao Y; Shapiro R; Schonder KS; Gao Y; Randhawa PS; Venkataramanan R
Transpl Infect Dis; 2013 Feb; 15(1):34-41. PubMed ID: 23025519
[TBL] [Abstract][Full Text] [Related]
2. Observations on the use of cidofovir for BK virus infection in renal transplantation.
Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
[TBL] [Abstract][Full Text] [Related]
3. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
Araya CE; Lew JF; Fennell RS; Neiberger RE; Dharnidharka VR
Pediatr Transplant; 2006 Feb; 10(1):32-7. PubMed ID: 16499584
[TBL] [Abstract][Full Text] [Related]
4. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.
Vats A; Shapiro R; Singh Randhawa P; Scantlebury V; Tuzuner A; Saxena M; Moritz ML; Beattie TJ; Gonwa T; Green MD; Ellis D
Transplantation; 2003 Jan; 75(1):105-12. PubMed ID: 12544881
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.
Kuypers DR; Vandooren AK; Lerut E; Evenepoel P; Claes K; Snoeck R; Naesens L; Vanrenterghem Y
Am J Transplant; 2005 Aug; 5(8):1997-2004. PubMed ID: 15996251
[TBL] [Abstract][Full Text] [Related]
6. [BK virus infections in pediatric kidney transplant recipients].
Mutlu D; Sağlık I; Koyun M; Comak E; Mutlu E; Uslu Gökçeoğlu A; Cağla Doğan S; Dinçkan A; Akbaş SH; Akkaya B; Akman S; Süleymanlar G; Colak D
Mikrobiyol Bul; 2013 Jul; 47(3):461-71. PubMed ID: 23971923
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients.
Caruso Brown AE; Cohen MN; Tong S; Braverman RS; Rooney JF; Giller R; Levin MJ
Antimicrob Agents Chemother; 2015 Jul; 59(7):3718-25. PubMed ID: 25733509
[TBL] [Abstract][Full Text] [Related]
8. Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation.
Lee SS; Ahn JS; Jung SH; Ahn SY; Kim JY; Jang HC; Kang SJ; Jang MO; Yang DH; Kim YK; Lee JJ; Kim HJ
Korean J Intern Med; 2015 Mar; 30(2):212-8. PubMed ID: 25750563
[TBL] [Abstract][Full Text] [Related]
9. Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
Philippe M; Ranchon F; Gilis L; Schwiertz V; Vantard N; Ader F; Labussiere-Wallet H; Thomas X; Nicolini FE; Wattel E; Ducastelle-Leprêtre S; Barraco F; Lebras L; Salles G; Michallet M; Rioufol C
Biol Blood Marrow Transplant; 2016 Apr; 22(4):723-730. PubMed ID: 26718666
[TBL] [Abstract][Full Text] [Related]
10. Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.
Cabello V; Margarit N; Díaz Pedrero M; Bernal G; Pereira P; Gentil MA
Transplant Proc; 2008 Nov; 40(9):2930-2. PubMed ID: 19010151
[TBL] [Abstract][Full Text] [Related]
11. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
[TBL] [Abstract][Full Text] [Related]
12. Treatment of refractory BK virus-associated nephropathy with cidofovir.
Kadambi PV; Josephson MA; Williams J; Corey L; Jerome KR; Meehan SM; Limaye AP
Am J Transplant; 2003 Feb; 3(2):186-91. PubMed ID: 12614296
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients.
Cundy KC; Petty BG; Flaherty J; Fisher PE; Polis MA; Wachsman M; Lietman PS; Lalezari JP; Hitchcock MJ; Jaffe HS
Antimicrob Agents Chemother; 1995 Jun; 39(6):1247-52. PubMed ID: 7574510
[TBL] [Abstract][Full Text] [Related]
14. Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients.
Lim WH; Mathew TH; Cooper JE; Bowden S; Russ GR
Nephrology (Carlton); 2003 Dec; 8(6):318-23. PubMed ID: 15012704
[TBL] [Abstract][Full Text] [Related]
15. Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience.
Kwon HJ; Kang JH; Lee JW; Chung NG; Kim HK; Cho B
Transpl Infect Dis; 2013 Dec; 15(6):569-74. PubMed ID: 24028353
[TBL] [Abstract][Full Text] [Related]
16. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant.
Savona MR; Newton D; Frame D; Levine JE; Mineishi S; Kaul DR
Bone Marrow Transplant; 2007 Jun; 39(12):783-7. PubMed ID: 17438584
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis.
Wolf DL; Rodríguez CA; Mucci M; Ingrosso A; Duncan BA; Nickens DJ
J Clin Pharmacol; 2003 Jan; 43(1):43-51. PubMed ID: 12520627
[TBL] [Abstract][Full Text] [Related]
18. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
[TBL] [Abstract][Full Text] [Related]
19. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of interstitial nephropathy caused by BK virus in renal transplantation. Therapeutic management with cidofovir plus probenecid].
Barrios C; Puig JM; Mir ML
Nefrologia; 2007; 27(6):774-5. PubMed ID: 18336115
[No Abstract] [Full Text] [Related]
[Next] [New Search]
